Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 20, 2006

OGT Grants DNA Sequence Variation Rights to Illumina

  • Illumina obtained permission to Oxford Gene Technology’s (OGT) patents for the detection of DNA sequence variations. The granted license will remain valid for the lifetime of the patents.

    Under the license agreement, Illumina gained certain rights with respect to SNP genotyping. “OGT’s technology combined with Illumina’s BeadArray™ technology gives customers access to an extremely powerful SNP detection platform,” says Sue Sutton, vp, Licensing North America at OGT.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »